Search by Drug Name or NDC

    NDC 42291-0773-60 Ranolazine 500 mg/1 Details

    Ranolazine 500 mg/1

    Ranolazine is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is RANOLAZINE.

    Product Information

    NDC 42291-0773
    Product ID 42291-773_0e9aba8f-2059-cea0-e063-6294a90a8241
    Associated GPIs 32200040007420
    GCN Sequence Number 060333
    GCN Sequence Number Description ranolazine TAB ER 12H 500 MG ORAL
    HIC3 A2C
    HIC3 Description ANTIANGINAL, ANTI-ISCHEMIC AGENTS,NON-HEMODYNAMIC
    GCN 26459
    HICL Sequence Number 033446
    HICL Sequence Number Description RANOLAZINE
    Brand/Generic Generic
    Proprietary Name Ranolazine
    Proprietary Name Suffix n/a
    Non-Proprietary Name RANOLAZINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name RANOLAZINE
    Labeler Name AvKARE
    Pharmaceutical Class Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212781
    Listing Certified Through 2025-12-31

    Package

    NDC 42291-0773-60 (42291077360)

    NDC Package Code 42291-773-60
    Billing NDC 42291077360
    Package 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42291-773-60)
    Marketing Start Date 2020-10-27
    NDC Exclude Flag N
    Pricing Information N/A